Eslo Adverse Reactions



Hetero Labs


Full Prescribing Info
Adverse Reactions
Adverse reaction are most frequent during the first or second week of treatment and usually decrease in intensity and frequency with continued treatment.
Adverse drug reaction known for SSRIs and also reported for Escitalopram.
Frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to ≤1/100), rare (≥1/10000 to ≤1/1000), very rare (≤1/10000), or not known (cannot be estimated from the available data). (See table.)

Click on icon to see table/diagram/image

The following adverse drug reactions have been reported for the therapeutic class of SSRIs: psychomotor restlessness/akathisia and anorexia.
Cases of QT-prolongation have been reported, predominantly in patients with pre-existing cardiac disease. No causal relationship has been established.
Discontinuation symptoms seen when stopping treatment.
Discontinuation of SSRIs/ SNRIs (particular when abrupt) commonly lead to and discontinuation symptoms. Dizziness, sensory disturbance (including paresthesia and electric shock sensations), sleep disturbances (including insomnia and intense dream), agitation or anxiety, nausea, and or vomiting, tremor, confusion, sweating, headache, diarrhea, palpitations, emotional instability, irritability and visual disturbances are the most commonly reported reactions. Generally these events are mild to moderate and are self-limiting, however in some patients they may be severe and/ or prolonged. It is therefore advised that when Escitalopram that when Escitalopram treatment is no longer required, gradual discontinuation by dose tapering and should be carried out.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in